Author:
Green Martin D.,Hartsough Melanie
Reference51 articles.
1. http://www.fda.gov/cder/guidance/1859fnl.pdf
2. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data;Obach;J Pharmacol Exp Therapeut,1977
3. Interspecies differences in cancer susceptibility and toxicity;Hengstler;Drug Metab Rev,1999
4. Importance of species selection in drug toxicity testing;Morton;Toxicol Letts,1998
5. Hepatic failure and lactic acidosis due to Fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B;McKenzie;N Eng J Med,1995